Chemoinformaics analysis of [(2E)-3-(ACETYLOXYMETHYL)-7-METHYLOCTA-2,6-DIENYL] ACETATE
| Molecular Weight | 254.326 | nRot | 7 |
| Heavy Atom Molecular Weight | 232.15 | nRig | 24 |
| Exact Molecular Weight | 254.152 | nRing | 0 |
| Solubility: LogS | -3.964 | nHRing | 0 |
| Solubility: LogP | -0.164 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 40 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 41.2574 |
| nHD | 0 | BPOL | 27.2786 |
| QED | 0.33 |
| Synth | 3.924 |
| Natural Product Likeliness | 1.672 |
| NR-PPAR-gamma | 0.874 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.879 |
| HIA | 0.885 |
| CACO-2 | -6.078 |
| MDCK | 0.0000361 |
| BBB | 0.218 |
| PPB | 0.830954 |
| VDSS | 0.831 |
| FU | 0.146063 |
| CYP1A2-inh | 0.038 |
| CYP1A2-sub | 0.084 |
| CYP2c19-inh | 0.019 |
| CYP2c19-sub | 0.065 |
| CYP2c9-inh | 0.011 |
| CYP2c9-sub | 0.418 |
| CYP2d6-inh | 0.047 |
| CYP2d6-sub | 0.206 |
| CYP3a4-inh | 0.06 |
| CYP3a4-sub | 0.028 |
| CL | 4.221 |
| T12 | 0.655 |
| hERG | 0.016 |
| Ames | 0.601 |
| ROA | 0.588 |
| SkinSen | 0.079 |
| Carcinogencity | 0.195 |
| EI | 0.011 |
| Respiratory | 0.047 |
| NR-Aromatase | 0.889 |
| Antiviral | Yes |
| Prediction | 0.779941 |